Cutting straight to the user question: Yes, BPC157 can be a risk, but the size of that risk depends on three things: 1
Through lengthy research, communicating with credible doctors, and gaining firsthand knowledge from one of our own team members, weve learned key details about TB4s and TB-500s safety, potential benefits, bioavailability, efficacy, patient experience, and much more
In sponge exudates, it remains active at the site of wounds for several hours (Tkalcevic et al., 2007)
However, complete symptom resolution often requires several weeks to months of consistent treatment